Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Thieme

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Stage-dependent biomarker changes in spinocerebellar ataxia type 3Jennifer Faber, Moritz Berger, Wilke Carlo, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohortMoritz Berger, Hector Garcia-Moreno, Monica Ferreira, et al.
The Lancet Regional Health. Europe|July 18, 2025
Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohortMoritz Berger, Hector Garcia-Moreno, Mónica Ferreira, et al.
Nature Communications|February 14, 2026
Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxiaBenita Menden, Rana D Incebacak Eltemur, German Demidov, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
Stage-dependent biomarker changes in spinocerebellar ataxia type 3Jennifer Faber, Moritz Berger, Wilke Carlo, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohortMoritz Berger, Hector Garcia-Moreno, Monica Ferreira, et al.
The Lancet Regional Health. Europe|July 18, 2025
Progression of biological markers in spinocerebellar ataxia type 3: longitudinal analysis of prospective data from the ESMI cohortMoritz Berger, Hector Garcia-Moreno, Mónica Ferreira, et al.
Nature Communications|February 14, 2026
Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxiaBenita Menden, Rana D Incebacak Eltemur, German Demidov, et al.
Pageof 4